BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24022755)

  • 21. MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance.
    Rosales-Aviña JA; Torres-Flores J; Aguilar-Lemarroy A; Gurrola-Díaz C; Hernández-Flores G; Ortiz-Lazareno PC; Lerma-Díaz JM; de Celis R; González-Ramella Ó; Barrera-Chaires E; Bravo-Cuellar A; Jave-Suárez LF
    J Exp Clin Cancer Res; 2011 Dec; 30(1):112. PubMed ID: 22185299
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
    Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification and analysis of conserved cis-regulatory regions of the MEIS1 gene.
    Royo JL; Bessa J; Hidalgo C; Fernández-Miñán A; Tena JJ; Roncero Y; Gómez-Skarmeta JL; Casares F
    PLoS One; 2012; 7(3):e33617. PubMed ID: 22448256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon.
    Spieler D; Kaffe M; Knauf F; Bessa J; Tena JJ; Giesert F; Schormair B; Tilch E; Lee H; Horsch M; Czamara D; Karbalai N; von Toerne C; Waldenberger M; Gieger C; Lichtner P; Claussnitzer M; Naumann R; Müller-Myhsok B; Torres M; Garrett L; Rozman J; Klingenspor M; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Beckers J; Hölter SM; Meitinger T; Hauck SM; Laumen H; Wurst W; Casares F; Gómez-Skarmeta JL; Winkelmann J
    Genome Res; 2014 Apr; 24(4):592-603. PubMed ID: 24642863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.
    Hess JL; Bittner CB; Zeisig DT; Bach C; Fuchs U; Borkhardt A; Frampton J; Slany RK
    Blood; 2006 Jul; 108(1):297-304. PubMed ID: 16507773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.
    Sun Y; Zhou B; Mao F; Xu J; Miao H; Zou Z; Phuc Khoa LT; Jang Y; Cai S; Witkin M; Koche R; Ge K; Dressler GR; Levine RL; Armstrong SA; Dou Y; Hess JL
    Cancer Cell; 2018 Oct; 34(4):643-658.e5. PubMed ID: 30270123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation.
    Mamo A; Krosl J; Kroon E; Bijl J; Thompson A; Mayotte N; Girard S; Bisaillon R; Beslu N; Featherstone M; Sauvageau G
    Blood; 2006 Jul; 108(2):622-9. PubMed ID: 16469876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations.
    Quentmeier H; Dirks WG; Macleod RA; Reinhardt J; Zaborski M; Drexler HG
    Leuk Lymphoma; 2004 Mar; 45(3):567-74. PubMed ID: 15160920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines.
    Wermuth PJ; Buchberg AM
    Blood; 2005 Feb; 105(3):1222-30. PubMed ID: 15479723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The deficiency of tumor suppressor prep1 accelerates the onset of meis1- hoxa9 leukemogenesis.
    Dardaei L; Modica L; Iotti G; Blasi F
    PLoS One; 2014; 9(5):e96711. PubMed ID: 24809472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
    Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
    Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells.
    von Burstin J; Bachhuber F; Paul M; Schmid RM; Rustgi AK
    Mol Carcinog; 2017 Mar; 56(3):936-944. PubMed ID: 27583552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
    Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
    Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.
    Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E
    Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis.
    Yokoyama T; Nakatake M; Kuwata T; Couzinet A; Goitsuka R; Tsutsumi S; Aburatani H; Valk PJ; Delwel R; Nakamura T
    J Clin Invest; 2016 May; 126(5):1664-78. PubMed ID: 27018596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.
    Pineault N; Helgason CD; Lawrence HJ; Humphries RK
    Exp Hematol; 2002 Jan; 30(1):49-57. PubMed ID: 11823037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
    Schneider E; Staffas A; Röhner L; Malmberg ED; Ashouri A; Krowiorz K; Pochert N; Miller C; Wei SY; Arabanian L; Buske C; Döhner H; Bullinger L; Fogelstrand L; Heuser M; Döhner K; Xiang P; Ruschmann J; Petriv OI; Heravi-Moussavi A; Hansen CL; Hirst M; Humphries RK; Rouhi A; Palmqvist L; Kuchenbauer F
    Haematologica; 2018 Feb; 103(2):246-255. PubMed ID: 29217774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memory.
    Stahlhut M; Ha TC; Takmakova E; Morgan MA; Schwarzer A; Schaudien D; Eder M; Schambach A; Kustikova OS
    Sci Rep; 2021 Mar; 11(1):5294. PubMed ID: 33674652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.